Module

The Evolving Role of Transplantation in Lymphoproliferative Malignancies

Source: Advances in the Treatment of Lymphoproliferative Malignancies: Promising Directions in Mantle Cell Lymphoma, Follicular Lymphoma, and Waldenstrom’s Macroglobulinemia

The Evolving Role of Transplantation in Lymphoproliferative Malignancies


CME Program Director: James O. Armitage, MD

Faculty:

  • John P. Leonard, MD

CME CREDIT INFORMATION

Release Date: 09/28/07

Expiration Date: 09/27/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review the use of stem cell transplantation in the treatment of patients with Waldenström’s macroglobulinemia
  • Discuss the differences between allogeneic and autologous stem cell transplantation in the treatment of patients with follicular and mantle cell lymphoma
  • Explain the use of stem cell transplantation in combination with other therapeutic modalities for the treatment of lymphoma

Topics covered include:

  • Introduction
  • Stem Cell Transplantation in Waldenström’s Macroglobulinemia
  • Stem Cell Transplantation in Follicular Lymphoma
  • Stem Cell Transplantation in Mantle Cell Lymphoma
  • Future Directions in Transplantation


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by University of Nebraska Medical Center, Center for Continuing Education and Clinical Care Options, LLC.

Educational grant provided by: